{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:35:54Z","timestamp":1774870554358,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22003","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T22:09:30Z","timestamp":1655849370000},"page":"164-168","source":"Crossref","is-referenced-by-count":1,"title":["Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.3960","volume":"62","author":[{"given":"Masahiro","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eijiro","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ferreri AJM, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol. 2012; 83: 293-302.","DOI":"10.1016\/j.critrevonc.2012.02.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Strullu M, Thomas C, Le Deley M-C <i>et al.<\/i> Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC. Bone Marrow Transplant. 2015; 50: 795-801.","DOI":"10.1038\/bmt.2015.57"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fukano R, Mori T, Kobayashi R <i>et al.<\/i> Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan. Br J Haematol. 2015; 168: 557-563.","DOI":"10.1111\/bjh.13167"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Miura Y, Fukuhara N, Yamamoto J <i>et al.<\/i> Clinicopathological features of malignant lymphoma in Japan: the Miyagi Study. Tohoku J Exp Med. 2011; 224: 151-160.","DOI":"10.1620\/tjem.224.151"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. J Clin Exp Hematop. 2017; 57: 120-142.","DOI":"10.3960\/jslrt.17023"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Sibon D, Fournier M, Bri\u00e8re J <i>et al.<\/i> Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte trials. J Clin Oncol. 2012; 30: 3939-3946.","DOI":"10.1200\/JCO.2012.42.2345"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Morel A, Bri\u00e8re J, Lamant L <i>et al.<\/i> Long-term outcomes of adults with first-relapsed\/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA\/SFGM-TC study. Eur J Cancer. 2017; 83: 146-153.","DOI":"10.1016\/j.ejca.2017.06.026"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Damm-Welk C, Pillon M, Woessmann W, Mussolin L. Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK. Front Biosci (Schol Ed). 2015; 7: 205-216.","DOI":"10.2741\/s434"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Woessmann W, Zimmermann M, Lenhard M <i>et al.<\/i> Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol. 2011; 29: 3065-3071.","DOI":"10.1200\/JCO.2011.34.8417"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pro B, Advani R, Brice P <i>et al.<\/i> Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol. 2012; 30: 2190-2196.","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Fukano R, Mori T, Sekimizu M <i>et al.<\/i> Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: an open-label phase II trial. Cancer Sci. 2020; 111: 4540-4547.","DOI":"10.1111\/cas.14671"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Domingo-Dom\u00e8nech E, Boumendil A, Climent F <i>et al.<\/i> Autologous hematopoietic stem cell transplantation for relapsed\/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. Bone Marrow Transplant. 2020; 55: 796-803.","DOI":"10.1038\/s41409-019-0734-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Yared J, Kimball A. The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: a review of the literature and new perspectives. Cancer Treat Rev. 2013; 39: 51-59.","DOI":"10.1016\/j.ctrv.2012.03.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Schmitz N, Lenz G, Stelljes M. Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas. Blood. 2018; 132: 245-253.","DOI":"10.1182\/blood-2018-01-791335"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ichikawa S, Fukuhara N, Onishi Y, Ichinohasama R, Harigae H. Sustained remission of gammadelta T-cell lymphoma by graft-versus-lymphoma effect that relapsed early after cord blood Transplantation. Clin Lymphoma Myeloma Leuk. 2018; 18: e369-e372.","DOI":"10.1016\/j.clml.2018.06.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ichikawa S, Fukuhara N, Saito K <i>et al.<\/i> Successful treatment of primary refractory angioimmunoblastic T-cell lymphoma with cord blood transplantation. Clin Lymphoma Myeloma Leuk. 2020; 20: e926-e929.","DOI":"10.1016\/j.clml.2020.07.009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hamadani M, Awan FT, Elder P <i>et al.<\/i> Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. Biol Blood Marrow Transplant. 2008; 14: 480-483.","DOI":"10.1016\/j.bbmt.2008.01.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Du J, Yu D, Han X, Zhu L, Huang Z. Comparison of allogeneic stem cell transplant and autologous stem cell transplant in refractory or relapsed peripheral T-cell lymphoma: A systematic review and meta-analysis. JAMA Netw Open. 2021; 4: e219807.","DOI":"10.1001\/jamanetworkopen.2021.9807"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Corradini P, Dodero A, Zallio F <i>et al.<\/i> Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol. 2004; 22: 2172-2176.","DOI":"10.1200\/JCO.2004.12.050"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Fukano R, Mori T, Fujita N <i>et al.<\/i> Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. Int J Hematol. 2019; 110: 723-728.","DOI":"10.1007\/s12185-019-02748-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Domingo-Dom\u00e8nech E, Boumendil A, Climent F <i>et al.<\/i> Allogeneic hematopoietic stem cell transplantation for patients with relapsed\/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2020; 55: 633-640.","DOI":"10.1038\/s41409-019-0732-9"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/3\/62_22003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T05:18:18Z","timestamp":1664601498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/3\/62_22003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22003","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22003"}}